Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ann Marie LeVine, Jodie Gwozdz, James Stark, Michael Bruno, Jeffrey Whitsett, Thomas Korfhagen
Published in Volume 103, Issue 7
J Clin Invest. 1999; 103(7):1015–1021 doi:10.1172/JCI5849
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6

SP-A enhanced RSV clearance from the lung of SP-A–/– mice. RSV titers were determined by quantitative plaque assays of lung homogenates 3 days after infection with 107 pfu of RSV. Viral titers in the lung were significantly reduced in SP-A–/– mice treated with SP-A (100 μg) (cross-hatched bar) compared with untreated SP-A–/– mice (filled bar) (a). Treatment of SP-A–/– mice with SP-A reduced viral titers to the wild-type level. Viral titers were similar in SP-A–treated (open bar) and untreated wild-type mice (hatched bar) (b). Data are mean ± SEM. *P < 0.05 compared with SP-A–/– mice. WT, wild-type.